Piramal Enterprises posts PAT at Rs554cr in Q2, up 15.3% yoy

"Our pharma revenues grew 19% yoy to Rs1,316cr in Q2," Ajay Piramal said.

Oct 22, 2019 08:10 IST India Infoline News Service

Piramal Enterprises
Piramal Enterprises Limited (PEL) reported an increase in its consolidated net profit by 15.3% at Rs554cr for the second quarter ended September 2019. The company had reported a net profit of Rs480.42cr for the July-September quarter a year ago.

Its total income was up 14.55% to Rs3,666.24cr during the quarter under review as against Rs3,200.41cr in the corresponding quarter of the previous fiscal.

Ajay Piramal, Chairman, Piramal Enterprises Ltd. said, “Our diversified business model has enabled us to deliver resilient performance during this quarter, despite continued liquidity tightening in the NBFC sector. Pharma and Healthcare Insights businesses continue to consistently deliver strong performance quarter on quarter, acting as a natural hedge and bringing stability to the company’s performance, even in the most volatile market environment. Our Pharma revenues grew 19% yoy to Rs1,316cr in Q2.”

Related Story